Trial NCT04385095 ; EudraCT 2020-001023-1
Publication Monk PD, Lancet Respir Med, 2020
Primary outcome on the report: change in clinical condition on the WHO Ordinal Scale for Clinical Improvement (OSCI) during the dosing period